Metabolic and Autoimmune Disorders

Showing all 5 results

  • Oxnard

    NASH/MASH

    Coming Soon! NASH/MASH is a quiet liver disease that often shows no symptoms until it's severe. It starts with extra liver fat and can lead to serious liver damage. Early action is key to preventing it from getting worse.   Criteria & Qualifications: • Must be over 18 years old.
    • Diagnosed with Fatty Liver Disease.
      Compensation: Contact us for more information.

    Read more
  • Camarillo, Oxnard

    NASH/MASH Study

    Nonalcoholic fatty liver disease (NAFLD) is a condition where fat accumulates in the liver. NASH, the more severe form, causes swelling and damage to the liver. Currently, there is no existing treatment for NASH/MASH.

    Criteria & Qualifications:  • Is at least 18 years of age or older.
    • Inflammation and liver damage, also known as Nonalcoholic steatohepatitis (NASH).
    • Must be weight stable for 6 months.
      Compensation: Up to $3,000.

    Read more
  • Santa Maria

    NASH/MASH Study

    NASH/MASH is a liver disease with inflammation and damage from fat buildup. If you have NASH/MASH, consider participating in our study to help find new treatments. Criteria & Qualifications:  • Must be 18 years or older.
    • Diagnosed with Ulcerative Colitis.
    • Is willing to provide medical records.

    Compensation: Contact us for more information.

    Read more
  • Santa Maria

    NASH/MASH Trial

    NASH/MASH, often a silent liver condition, typically remains undetected until it becomes advanced. It begins with an accumulation of fat in the liver and can progress to significant liver injury. Taking early measures is crucial to curb its severity.   Criteria & Qualifications:  • Participants need to be aged 18 or older.
    • Must have a diagnosis of Fatty Liver Disease.
      Compensation: Contact us for more information.

    Read more
  • Oxnard

    Obesity Study

    This clinical trial investigates the effects of a new medication on morbidity and mortality in adults experiencing obesity. The study aims to provide substantial evidence of the drug’s potential clinical benefits for obesity management.

    Criteria & Qualifications: • Males and Females in good general health.
    • BMI greater than 27.

    Compensation: Up to $800.

    Read more